Enomoto Torai, Okada Hideshi, Tomita Hiroyuki, Iinuma Koji, Nakane Keita, Tobisawa Yuki, Hara Akira, Koie Takuya
Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan.
Department of Urology, Matsunami General Hospital, Gifu, Japan.
Front Cell Dev Biol. 2024 Jan 10;11:1308879. doi: 10.3389/fcell.2023.1308879. eCollection 2023.
The abnormal glycocalyx (GCX) on the surface of cancer cells has been reported to be tall and aberrantly glycosylated and has been linked to the progression and spread of cancer-a finding also observed in bladder cancer. However, the characteristics of GCX in various types of human bladder cancer remain unknown, and herein, we aimed to provide information on the diversity of glycan components in the GCX of bladder cancers and to shed light on their characteristics. We used scanning electron microscopy and lanthanum staining to examine the surface GCX of human bladder carcinomas in three-dimensional images, showing the bulky GCX in some carcinomas. We also examined glycan alterations in early to progressive stages of bladder cancers using 20 distinct lectin stains on frozen sections from transurethral resection of bladder tumors. Distinctive Vicia villosa lectin (VVL) staining was observed in invasive urothelial carcinomas, including those with muscle invasion and variant components. In the clinical setting, cancers with atypia of grades 2-3 had a significantly higher VVL scoring intensity than those with grade 1 atypia ( < 0.005). This study identified that a specific lectin, VVL, was more specific to invasive urothelial carcinomas. This lectin, which selectively binds to sites of cancer progression, is a promising target for drug delivery in future clinical investigations.
据报道,癌细胞表面异常的糖萼(GCX)较高且糖基化异常,这与癌症的进展和扩散有关——在膀胱癌中也观察到了这一现象。然而,不同类型人类膀胱癌中糖萼的特征仍不清楚。在此,我们旨在提供膀胱癌糖萼中聚糖成分多样性的信息,并阐明其特征。我们使用扫描电子显微镜和镧染色在三维图像中检查人膀胱癌的表面糖萼,发现一些癌组织中有大量的糖萼。我们还使用20种不同的凝集素染色剂对经尿道膀胱肿瘤切除的冰冻切片进行检测,以研究膀胱癌从早期到进展期的聚糖变化。在浸润性尿路上皮癌中观察到了独特的野豌豆凝集素(VVL)染色,包括那些伴有肌肉浸润和变异成分的癌。在临床环境中,2-3级异型性的癌症的VVL评分强度显著高于1级异型性的癌症(<0.005)。本研究确定,一种特定的凝集素VVL对浸润性尿路上皮癌更具特异性。这种凝集素选择性地结合癌症进展部位,是未来临床研究中有前景的药物递送靶点。